Brief: Creso Pharma Says Unit Got Research Ethics Board Approval For Patient Recruitment For Phase II Clinical Trial For Psilocybin

Melodiol Global Health

14/09/2022 02:27

Sept 14 (Reuters) - Creso Pharma Ltd  CPH.AX :
    * UNIT SECURES RESEARCH ETHICS BOARD APPROVAL AND COMMENCES
PATIENT RECRUITMENT FOR PHASE II CLINICAL TRIAL FOR  PSILOCYBIN

Source text for Eikon:  ID:nASX5gCTdv 
Further company coverage:  CPH.AX 

 ((Reuters.Briefs@thomsonreuters.com;))